clinical trial · NCT06871046
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
Teikoku Seiyaku Co., Ltd.·phase3·completed·n = 221
ContusionsEsflurbiprofen Topical System (EFTS)
brief summary
This study is an open-label, multi-centric clinical trial to evaluate the safety and efficacy of TK-254RX in patients with contusions. The primary objective of this study is to assess the safety of TK-254RX. Secondly objective is to evaluate the efficacy of contusions and adhesion of TK-254RX.
started
Feb 20, 2025
primary completion
Sep 22, 2025
completion
Oct 1, 2025
last updated
Oct 24, 2025
official title
An Open-label, Multi-centric Trial to Assess the Safety and Efficacy of an Esflurbiprofen Topical System (EFTS) in the Local Symptomatic and Short-term Treatment of Pain in Contusions.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol